AXL is highly expressed in the mononucleated cells, blasts, and leukemic stem cells of AML patients and is correlated with a poor prognosis, whereas other TAM receptors lacked prognostic relevance in AML patients [76,77]. Here, AXL is linked to acute myeloid leukemia.